NEW: BAVENO VI Report on management of portal hypertension

EXPANDING CONSENSUS IN PORTAL HYPERTENSION Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. Abstract: Portal hypertension is the haemodynamic abnormality associated with the most severe complications of cirrhosis, including ascites, hepatic encephalopathy and bleeding from gastroesophageal varices. Variceal bleeding is a medical emergency associated with a mortality that, in spite of recent progress, is still in the order of 10-20% at 6 weeks. The evaluation of diagnostic tools and the design and conduct of good clinical trials for the treatment of portal hypertension have always been difficult. Read full text   <- Back to...

Management with NOACs: Practical challenges and future perspectives

Join an expert panel as they discuss contemporary data related to the use of NOACs for the prevention and treatment of thromboembolic events. Tuesday, June 23, 2015 Event time: 12:15 - 13:45 ISTH 2015 Congress, Metro Toronto Convention Centre, Room: 717 222 Bremner Blvd, Toronto, ON M5V 3L9, Canada More information: www.medscape.org/sites/townhall/public/antagonist-oral-anticoagulants   <- Back to News Presenters: Walter Ageno, MD Associate Professor of Medicine, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy   Mark Crowther, MD, FRCPC Professor, McMaster University, Hamilton, Ontario, Canada     Michael Spannagl, MD Professor, Department of Hemostasis and Transfusion Medicine, University of Munich, Munich, Germany     Robert P. Giugliano, MD Senior Investigator, TIMI Study Group; Physician, Cardiovascular Medicine, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, United...